1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
6C9F37412172F0119652580050043BCCF
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/db-best-practices-medical-education-programs-benchmarking-roles-regional-focus-multi-disciplinary?opendocument
18
19opendocument
2018.232.99.123
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




» Products & Services » » Medical Affairs » Medical Education

Best Practices in Medical Education Programs: Benchmarking Roles, Regional Focus and Multi-disciplinary Program Utilization

ID: 5423


Features:

8 Info Graphics

22 Data Graphics

300+ Metrics


Pages/Slides: 39


Published: 2016


Delivery Format: Online PDF Document


 

License Options:
close

Single User: Authorizes use by the person who places the order or for whom the order was placed.

Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.

Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.




Buy Now

 


  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
Non-members: Click here to review a complimentary excerpt from "Best Practices in Medical Education Programs: Benchmarking Roles, Regional Focus and Multi-disciplinary Program Utilization"

STUDY OVERVIEW

The pharmaceutical industry has long relied on medical education programs to successfully inform physicians and other health care professionals about the latest trends in therapies and treatment approaches.

As regulatory and market pressures reshape approaches to medical education programs, it is important to understand trends in the role medical education groups are playing in key activities, the use of education programs in different regions, the continued growth of multi-disciplinary programs, and the use of grants & accredited vs. non-accredited programs.

Best Practices, LLC undertook benchmarking research to investigate all of these emerging medical education trends at pharmaceutical and medical device organizations. Additionally, the study highlights program types and curricular topics that are preferred by physicians.


KEY TOPICS

  • Role Played By Medical Education Groups
  • Medical Education Groups: Regional Focus
  • Collaborative & Multi-Disciplinary Approaches To Medical & Clinical Education
  • Value Of Medical Education Formats

KEY METRICS
  • Roles Played by Medical Education Function in Conducting Important Activities Related to Thought Leaders, Professional Societies, Education Programs and Compliance
  • Percentage of Total Medical Education Programs Deployed Across Different Regions
  • Anticipated Trends in Regional Education and Multi-Disciplinary Education Programs
  • Principal Drivers of Multi-Disciplinary Programs
  • Most Effective Programs in Supporting Positive Patient Outcomes
  • Mix of Multi-Disciplinary Programs Provided Through Accredited and Non-Accredited Sources
  • Percentage of Company-Sponsored Accredited and Non-Accredited Education Programs Presented through Professional Associations/Societies Programs
  • Trends Regarding the Number of Grants to Professional Associations/Societies for Accredited and Non-Accredited Education Programs
  • Types of Professional Education, Curricular Topics, Company Professionals and Information Sources that are Most Valued by Physicians


SAMPLE KEY FINDINGS
  • Medical Education is Uniquely Poised to Help Fuel Growth in Emerging Markets: More than 75% of programs at benchmark companies were deployed in North America, while 9% in Europe. In next 2-3 years, benchmark partners foresee no deployment changes in North America. In contrast, more than two-thirds of companies plan to expand their clinical education efforts across emerging markets, Asia and Latin America.
  • Companies Supporting More Of Multi-Disciplinary Education Programs: Two out of three companies support multi-disciplinary education programs. The primary drivers of multi-disciplinary education programs are increasing focus on health outcomes (67%) and holistic approaches towards treatment (56%).


METHODOLOGY

Best Practices, LLC engaged 23 leaders supporting medical education at 19 leading bio-pharmaceutical and medical device companies through benchmarking research. More than 65% of research participants are at the director level.


Industries Profiled:
Health Care; Pharmaceutical; Diagnostic; Biotech; Medical Device; Biopharmaceutical; Chemical


Companies Profiled:
Abbott; Acorda Therapeutics; Astellas; AstraZeneca; BARD; Baxalta; Baxter International; Boehringer Ingelheim; Covidien; Daiichi Sankyo; Elekta; Ferring Pharmaceuticals; Genentech; Hospira; Lundbeck; Orthofix; Pfizer; Sunovion; UCB Pharma

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.